[A prospective study of neurodevelopment of uninfected children born to human immunodeficiency virus type 1 positive mothers].

Grupo de Inmunovirología, Facultad de Medicina, Universidad de Antioquía, Medellín, Colombia.
Revista de neurologia (Impact Factor: 0.93). 48(6):287-91.
Source: PubMed

ABSTRACT The human immunodeficiency virus type 1 (HIV-1) has tropism for the immune and central nervous systems (CNS). Intrauterine exposure to HIV-1 induces immunological alterations, independent of infection that might affect the development of the CNS. Similarly, the intrauterine exposure to antiretrovirals might also affect the neurodevelopment.
To evaluate the neurodevelopment of babies born to HIV-1 positive mothers (exposed) and compare with babies born to HIV-1 negative mothers (unexposed).
We carried-out an observational prospective study of neurodevelopment of 23 exposed and 20 unexposed children using the infant development scale Bayley-II, and the Denver-II test, neurological examination and anthropometric measurements during the first two years of life.
None of the exposed babies acquired the infection. At one month of age the exposed babies exhibit normal but statistically lower values in the head circumference, compared to unexposed neonates. No differences were found in the psychomotor development index between both studied groups and exposed babies exhibited a lower mental development index but only at six months of age. The exposed babies exhibited a higher number of alterations during the neurological and Denver-II tests without reaching significant differences.
The results suggest that intrauterine exposure to HIV-1 and to antiretrovirals in uninfected children born to HIV-1 positive mothers does not induce alterations in the neurodevelopment, at least during the first two years of life.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective:To determine whether there is a higher risk for cognitive or language delay among HIV-exposed uninfected (HEU) children exposed to cART (zidovudine/lamivudine/lopinavir/ritonavir) in utero and through 1 year of breast-feeding (World health Organization Option B+), compared with the control children born to HIV-uninfected mothers.Design:This is a double cohort study from Lusaka, Zambia.Methods:HEU (n=97) and control (n=103) children aged 15-36 months were assessed on their early nonverbal problem-solving and language skills using the standardized Capute Scales. A score of less than 85 on the Capute Full-Scale Developmental Quotient (FSDQ) was considered indicative of developmental delay and was the primary outcome of interest.Results:An FSDQ of less than 85 was found in eight (8.3%) of HEU participants and 15 (14.6%) of controls. In univariate logistic regressions, lower income [odds ratio (OR)=0.93, P=0.02], older infant age (OR=1.08, P=0.03), lower birth weight (OR=0.16, P<0.001), and less maternal education (OR=0.41, P=0.047) were associated with the probability of FSDQ less than 85, whereas Group (control/HEU) was not (OR=1.88, P=0.16). In the multivariable analysis, only lower birth weight (OR=0.15, P<0.001) remained associated with FSDQ less than 85.Conclusions:Our study did not support the presence of an adverse effect on cognitive and language development with prolonged antepartum and postpartum cART e/xposure. Larger studies and studies of older HEU children will be required to confirm these reassuring findings.
    AIDS (London, England) 07/2014; 28 Suppl 3:S323-S330. DOI:10.1097/QAD.0000000000000357 · 6.56 Impact Factor